Yes, capsaicin 0.075% can be used for knee pain, particularly for osteoarthritis-related knee pain.
The 2020 VA/DoD guidelines suggest offering topical capsaicin (0.025% to 0.075%) for patients with knee osteoarthritis pain, based on evidence showing at least a moderate effect in reducing moderate knee pain 1.
Evidence Quality and Strength
The recommendation is supported by:
- Guideline strength: Weak/conditional recommendation from the most recent 2020 VA/DoD guidelines 1
- Evidence base: Systematic review by Laslett and Jones including 5 RCTs comparing capsaicin 0.025% to 0.075% versus placebo, showing a standard mean difference of 0.44 in reducing moderate knee pain from OA 1
- 2019 ACR/Arthritis Foundation guidelines: Conditional recommendation for topical capsaicin in knee OA 2
Important Clinical Considerations
Mechanism and Timeline
Capsaicin works by depleting substance P (a pain neuropeptide) through reversible depletion. You must counsel patients that capsaicin needs continuous use for 2 to 4 weeks before therapeutic effect is experienced 1. Initial application causes pain and burning as it triggers substance P release, but continued use depletes it and reduces pain.
Application Instructions
Per FDA labeling 3:
- Apply thin film to affected area 3-4 times daily
- Rub in until fully absorbed
- Wash hands thoroughly after application (unless treating hands)
- Approved for adults and children ≥18 years
Expected Adverse Effects
Burning or stinging at application site is common and expected 1. Meta-analysis shows capsaicin increases burning sensation risk (risk ratio = 5.56, numbers needed to harm = 3) 4. This typically occurs in the first week and diminishes with continued use 5.
Contraindications and Warnings
Per FDA labeling 3:
- Do not use on wounds or damaged skin
- Do not use if allergic to capsicum or chili peppers
- Avoid contact with eyes, lips, nose, mucous membranes
- Do not tightly wrap or bandage treated area
- Do not apply heat before or after use
Divergent Evidence
Important caveat: The 2012 ACR guidelines conditionally recommended against using topical capsaicin for knee OA 6. However, this has been superseded by:
- 2019 ACR/Arthritis Foundation guidelines making a conditional recommendation for capsaicin 2
- 2020 VA/DoD guidelines suggesting offering capsaicin 1
The shift reflects accumulating evidence, though the recommendation remains conditional/weak rather than strong.
Efficacy Data
Recent systematic review and meta-analysis (2024) showed capsaicin (0.0125%-5%) may reduce pain severity (standardized mean difference = -0.84) compared to placebo at follow-ups up to 3 months 4. However, the certainty of evidence was rated as low-to-very-low due to short study durations, small sample sizes, and high heterogeneity.
Clinical Algorithm for Use
- Confirm diagnosis: Knee osteoarthritis with mild-to-moderate pain
- Check contraindications: No open wounds, no capsicum allergy
- Set expectations: Explain 2-4 week delay before benefit, initial burning sensation
- Prescribe: 0.075% capsaicin cream applied 3-4 times daily
- Follow-up: Reassess at 4 weeks; if no benefit, consider alternative topical (e.g., topical NSAIDs which have stronger evidence) 1
Position in Treatment Hierarchy
Capsaicin is not first-line. The 2020 VA/DoD guidelines give a strong recommendation for topical NSAIDs (diclofenac) for knee OA pain 1, while capsaicin receives only a weak/conditional recommendation. Consider capsaicin when:
- Topical NSAIDs are contraindicated or ineffective
- Patient prefers non-NSAID option
- As adjunct to other therapies
Hip Pain Caveat
Do not use capsaicin for hip pain. There is insufficient evidence for hip OA, and given the depth of the hip joint, topical agents are unlikely to provide benefit 1.